Allergan

Allergan

Allergan is a Dublin-based company founded in 2015 by Allen Chao.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

June 25, 2019
The drugmaker AbbVie announces it plans to buy Allergan, the maker of Botox, for about $63 billion.

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
AbbVie
February 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- AbbVie (NYSE: ABBV) announced financial results for the fourth quarter and full year ended December 31, 2020. "We successfully completed the...
Ben Adams
January 5, 2021
FierceBiotech
Sosei has become the latest victim of AbbVie's post-Allergan merger clear-out as the new suitor has decided to dump its former partner.
AbbVie
January 5, 2021
www.prnewswire.com:443
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive top-line results from two Phase 3 studies in adults with active psoriatic arthritis, KEEPsAKE-1...
Sosei Heptares
January 5, 2021
www.prnewswire.com:443
/PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) announces it is to regain the worldwide rights to its muscarinic agonist programs. The...
Camille Samuels
December 23, 2020
Business Insider
Venrock partner Cami Samuels says to communicate using the Goldilocks principle and don't hire a banker until you have a term sheet.
AbbVie
December 11, 2020
www.prnewswire.com:443
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP)...
Research and Markets
December 9, 2020
www.prnewswire.com:443
/PRNewswire/ -- The "Global Intragastric Balloon Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global intragastric balloon...
Research and Markets
November 9, 2020
www.prnewswire.com:443
/PRNewswire/ -- The "Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
Alex Keown
May 22, 2020
BioSpace
Pharma and life sciences companies bolster their executive leadership teams and boards with these Movers & Shakers.
BioSpace
May 18, 2020
BioSpace
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Matthew Walsh and Rachel Stahler as Chief Financial Officer and Chief Information Officer, respectively, for Organon & Co., its intended spinoff of its women's health, legacy brands and biosimilars businesses.
Conor Hale
May 15, 2020
FierceBiotech
The FDA issued two warning letters to breast implant manufacturers this week, including Allergan for failing to complete postmarket safety studies documenting the risks of two implant models the company took off the worldwide market last year.
John Miller
January 27, 2020
U.S.
U.S. drugmaker AbbVie's $63 billion tie-up with Allergan is getting help from Nestle and AstraZeneca buying up products the Irish-domiciled company is shedding to placate regulators.
Reuters Editorial
January 27, 2020
IN
Nestle on Monday said it is buying Allergan's Zenpep to expand in medical nutrition with a product for people who cannot digest food properly because their pancreas does not provide enough enzymes to break down fat, protein, and carbohydrates.
Reuters Editorial
September 27, 2019
U.S.
The U.S. Federal Trade Commission (FTC) has requested for more information from AbbVie Inc and botox maker Allergan Plc on their $63 billion deal, the companies said on Friday.
Michael J. de la Merced
June 25, 2019
www.nytimes.com
The deal would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira.
Allergan plc
May 15, 2019
www.prnewswire.com:443
DUBLIN, May 15, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced it will showcase data during the...
Medicines360
May 6, 2019
www.prnewswire.com:443
SAN FRANCISCO and DUBLIN, May 6, 2019 /PRNewswire/ -- Medicines360, a nonprofit women's health pharmaceutical company with a mission of expanding access to...
By SAPNA MAHESHWARI
April 12, 2019
www.nytimes.com
Less than halfway through April, companies have announced plans to close 5,994 stores, above the 5,854 that shut last year.
Reuters Editorial
Invalid Date
U.S.
Appaloosa LP said on Thursday minority investor John Chevedden was backing the hedge fund's proposal to split the roles of chairman and chief executive officer at Botox-maker Allergan Plc.
Reuters Editorial
Invalid Date
U.S.
Billionaire hedge fund manager David Tepper said on Tuesday Allergan Plc should consider selling itself if its management is unable to turn around recent lagging performance, stepping up pressure on the drugmaker.
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.